Bain Capital Life Sciences Investors

Bain Capital Life Sciences Investors as of June 30, 2021

Portfolio Holdings for Bain Capital Life Sciences Investors

Bain Capital Life Sciences Investors holds 30 positions in its portfolio as reported in the June 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Springworks Therapeutics (SWTX) 31.5 $481M 5.8M 82.41
Atea Pharmaceuticals (AVIR) 7.9 $121M 5.6M 21.48
Dynavax Technologies (DVAX) 7.6 $116M 12M 9.85
Dicerna Pharmaceuticals 7.5 $115M 3.1M 37.32
Arcutis Biotherapeutics (ARQT) 7.1 $109M 4.0M 27.29
Annexon (ANNX) 4.8 $73M 3.2M 22.51
C4 Therapeutics Com Stk (CCCC) 4.1 $62M 1.6M 37.84
Pharvaris N V (PHVS) 3.9 $59M 3.2M 18.63
Mersana Therapeutics (MRSN) 3.3 $50M 3.7M 13.58
Nurix Therapeutics (NRIX) 2.2 $34M 1.3M 26.53
Crinetics Pharmaceuticals In (CRNX) 2.1 $32M 1.7M 18.85
Syros Pharmaceuticals 2.1 $32M 5.8M 5.45
Solid Biosciences 1.9 $29M 7.9M 3.66
Marinus Pharmaceuticals (MRNS) 1.7 $26M 1.4M 17.94
Aptinyx 1.6 $25M 8.9M 2.83
Kymera Therapeutics (KYMR) 1.5 $23M 480k 48.50
Nautilus Biotechnology (NAUT) 1.3 $20M 2.0M 10.10
Savara (SVRA) 1.3 $20M 12M 1.70
Aeglea Biotherapeutics 1.2 $19M 2.7M 6.96
Bluebird Bio (BLUE) 1.1 $17M 538k 31.98
X4 Pharmaceuticals (XFOR) 0.9 $14M 2.1M 6.50
Bctg Acquisition Corp 0.7 $11M 922k 11.38
Research Alliance Corp Ii Com Cl A 0.7 $10M 1.0M 10.14
Arya Sciences Acqu Corp Iv Cl A (ARYD) 0.5 $7.5M 700k 10.72
Bcls Acquisition Corp Com Cl A 0.3 $5.1M 488k 10.53
Panacea Acquisition Corp Ii Cl A Shs 0.3 $5.0M 500k 10.02
Omega Alpha Spac Cl A 0.3 $4.0M 400k 9.95
Frazier Lifesciences Acqu Unit 12/09/2025 0.2 $3.0M 300k 10.05
Jiya Acquisition Corp Com Cl A 0.2 $3.0M 300k 9.94
Helix Acquisition Corp Com Cl A 0.2 $2.6M 250k 10.35